stomach cancer
MiRxes Gets $50M in Series D Funding, Applies to Hong Kong Limited Stock Exchange
The firm plans to use the investment to scale adoption and penetration of its flagship stomach cancer blood test in Asia-Pacific markets and to develop other assays.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.
Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test
The firm presented initial study results from the test, which identifies six cancers, showing overall sensitivity at 86 percent and specificity of 95 percent.
Microbiome-Based Cancer Dx Emerges From Cancer Genome Atlas Reanalysis
Researchers re-examined whole-genome and whole-transcriptome sequencing TCGA studies from 33 cancer types and found unique microbial signatures.
Jul 11, 2019
Cancer Detection Firm StageZero Raises C$2.7M
Feb 14, 2017